A stereoselective synthetic route to homo‐ and heteroleptic facial tris‐cyclometalated PtIV complexes is reported, involving the oxidative addition of 2‐(2‐pyridyl)‐ or 2‐(1‐isoquinolinyl)benzenediazonium salts to cis‐[Pt(C^N)2] precursors, with C^N=cyclometalated 2‐(p‐tolyl)pyridine (tpy), 2‐phenylquinoline (pq), 2‐(2‐thienyl)pyridine or 1‐phenylisoquinoline (piq), to produce labile diazenide intermediates that undergo photochemical or thermal elimination of N2. The method allows the preparation of derivatives bearing cyclometalated ligands of low π–π* transition energies. The new complexes exhibit phosphorescence in fluid solution at room temperature arising from triplet ligand‐centered (3LC) excited states, which, in the cases of the heteroleptic derivatives, involve the ligand with the lowest π–π* gap. The heteroleptic piq derivatives exhibit fluorescence and dual phosphorescence from different ligand‐centered excited states in rigid media, demonstrating the potential of cyclometalated PtIV complexes as multi‐emissive materials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.